Introduction {#s1}
============

Cervical spondylotic myelopathy (CSM) is a clinically symptomatic condition caused by compression of the spinal cord due to degeneration. It is a significant cause of disability in the adult population [@pone.0087191-Carette1]--[@pone.0087191-Ghogawala1], notably causing progressive degenerative changes in the cervical spine of patients over 55 years of age [@pone.0087191-Toledano1], [@pone.0087191-Lebl1]. CSM is a common cause of neurological morbidity, and can substantially decrease quality of life [@pone.0087191-Young1]. The principal indication for surgery for CSM is the development of progressive spinal cord type symptoms and signs [@pone.0087191-Sypert1]. Surgical treatment has been advocated for CSM by many authors, however, the optimal surgical approach remains controversial. Anterior, posterior and combined anterior and posterior surgical approaches for CSM have all been proposed and encouraged. Anterior approaches usually involve anterior cervical discectomy with fusion (ACDF) or anterior cervical corpectomy with fusion (ACCF), whereas posterior cervical canal decompression approaches typically involve laminoplasty and laminectomy. In terms of anterior procedures, there is considerable controversy as to which reconstruction technique is best after anterior cervical decompression. The anterior approach to the cervical spine was developed in the 1950s by Smith [@pone.0087191-Smith1] and Cloward [@pone.0087191-Cloward1]. ACDF can decompress the anterior spinal cord, preserve the stability of the spinal column and is associated with a low prevalence of graft extrusion or migration. However, some authors argue that ACDF may not be the optimal surgical approach for CSM due to the risk of incomplete decompression, limited visual exposure, and a high rate of non-union due to graft--host interfaces [@pone.0087191-Oh1], [@pone.0087191-Fountas1]. An alternate means of improving the fusion rate after multi-level decompression is the use of ACCF [@pone.0087191-Gore1]. In addition to improving the fusion rate, ACCF also provides for a more extensive decompression and serves as a source for autografting. Unfortunately, ACCF is a more difficult spinal surgery to perform and is also associated with a higher incidence of complications, such as increased risk of damage to the spinal cord or nerve roots, excessive bleeding, graft displacement or extrusion, and others [@pone.0087191-Wang1]--[@pone.0087191-Vaccaro1].

The results of previous studies comparing the clinical effects of ACDF to ACCF for the treatment of CSM vary considerably. It is still uncertain whether ACDF is safer and more effective than ACCF. Therefore, to clarify these ambiguous findings we performed a meta-analysis to compare ACDF with ACCF for the treatment of CSM.

Methods {#s2}
=======

2.1 Search strategies {#s2a}
---------------------

To assemble all of the relevant literature, a search of relevant systematic reviews on CSM in the Cochrane Library (Cochrane library 2013), observational cohort studies (with and without control groups), systematic reviews, and clinical trials was conducted in MEDLINE (1966 to July 2013), EMBASE (1974 to July 2013), PubMed (1966 to July 2013) and Google Scholar (1966 to July 2013). The following search terms were used: cervical spondylotic myelopathy, cervical spine, discectomy, corpectomy, cervical spondylosis, surgical decompression, spinal fusion, and complications, with various combinations of the operators "AND", "NOT", and "OR". We restricted the language to English. References cited in relevant articles and reviews were checked to identify additional studies. The full search strategy is available upon request from the corresponding authors (**Wang and Tan**).

The quality of the studies was independently assessed by two authors (Han and Liu), and the level of agreement between them was recorded. The decision on whether to include an article was made by manual screening of titles and abstracts, followed by full-text screening by the same reviewers. If additional data or clarification were necessary, we contacted the study authors. Any disagreements between reviewers were resolved by discussion with another reviewer (**Wang**).

2.2 Eligibility criteria {#s2b}
------------------------

Studies were included if they met the following criteria: (1) adult patients over 18 years of age of both genders with CSM; (2) randomized or non-randomized controlled clinical studies; (3) studies compared ACDF with ACCF for treatment of CSM; (4) post-operative follow-up with included patients was for a minimum of 24 months; and (5) outcome assessment was based on the primary and secondary outcomes. The primary outcome was defined as major surgical complications, radiographic outcomes, fusion rate, or patient-related outcome measures regarding pain and quality of life using various validated questionnaires, such as the Japanese Orthopedic Association score (JOA), the Visual Analogue Score (VAS), the Neck Disability Index (NDI), and Odom criteria, among others. The secondary outcome included surgical data, such as the operation time, blood loss and length of hospital stay.

2.3 Exclusion criteria {#s2c}
----------------------

Studies were excluded if they (1) had an average follow-up time of less than 24 months; (2) were uncontrolled; (3) described case reports or were systematic reviews; (4) dealt only with combined ACDF and ACCF surgery versus ACDF or ACCF alone for treatment of CSM.

2.4 Data extraction and management {#s2d}
----------------------------------

Data were extracted independently by two reviewers (Han and Liu). Discussions were conducted to deal with disagreements, and when necessary, discussions included another independent expert (**Wang**). The following information was collected from each study: (1) general characteristics, including the authors, the year of publication, sample size, age, gender, duration of follow-up and the type of graft ([*Table 1*](#pone-0087191-t001){ref-type="table"}); and (2) details of the clinical outcome measurement: the length of hospital stay, blood loss, operation time, JOA, VAS, NDI, Odom criteria, fusion rate, Cobb angles of C2--C7, segmental angle complications, and the type of complications, such as dysphagia, hoarseness, C5 palsy, infection, cerebral fluid leakage, donor site pain, epidural hematoma, graft related and hardware-related complications (*Tables 2 and 3*). All included studies met the inclusion and exclusion criteria. The extracted data were rechecked for accuracy or against the inclusion criteria by **Wang**.

10.1371/journal.pone.0087191.t001

###### Characteristics of the included studies.

![](pone.0087191.t001){#pone-0087191-t001-1}

  Study                                         Publition year   Sample Size   Mean age(years)   Sex(male/female)   Followup(months,years)        Graft                                                                                                                
  -------------------------------------------- ---------------- ------------- ----------------- ------------------ ------------------------ ------------------ ----------------- ---------------- ---------------- --------------------------------------------------- -------------------------------------------------
  Li et al.[@pone.0087191-Li1]                       2013            47              42              51.3±6.5              58M/31F              79.6±20.5m      Autograft,cage    Autograft,cage                                                                       
  Liu et al.[@pone.0087191-Liu2]                     2012            69              39              46.1±6.8              47.8±6.4              39M/30F            26M/13F       26.8m(12--29m)   26.4m(12--37m)                 Cages,Atlantis plate                         Titanium mesh cage,Atlantis plate
  Kyung et al.[@pone.0087191-Song1]                  2012            25              15              50.3±7.5              54.1±9.8               19M/6F            11M/4F          87.3±21.7m       94.3±25.3m                    Autograft and cage                                      Autograft
  Lin et al.[@pone.0087191-Lin1]                     2012            57              63             58.74±9.7             57.90±9.0              38M/19F            43M/20F            24m              24m         Autograft,cages, semi-constrained plating systems   Autograft,TMC, semi-constrained plating systems
  Guo et ai.[@pone.0087191-Guo1]                     2011            43              24              52.7±9.4             55.2±10.1              24M/19F            13M/11F         37.7±7.2m        37.3±7.3m                  Autograft and PEEK cages                          Autograft and Titanium cage
  Park et al.[@pone.0087191-Park1]                   2010            45              52              49.3±9.7              49.4±8.7              28M/17F            22M/30F         25.7±6.2m        23.3±6.6m                          Allograft                                          Allograft
  Oh et al.[@pone.0087191-Oh1]                       2009            14              17             54.45±11.6             16M/15F             26.23±15.0m      Cage, allograft     Autograft                                                                          
  Uribe et al.[@pone.0087191-Uribe1]                 2009            42              38                46.2                  50.0                21M/21F            21M/17F         2.3 years        2.2 years                Titanium mesh cages,autograft                      Titanium mesh cages,autograft
  Hwang et al.[@pone.0087191-Hwang1]                 2007            27              35                54.2                  52.2                13M/14F            19M/16F            24m              24m                   Titanium mesh cages,autograft                      Titanium mesh cages,autograft
  Nirala et al.[@pone.0087191-Nirala1]               2004            69              132                55                    44                 40M/29F            80M/52F            54m              48m                             Autograft                                          Autograft
  Hilibrand et al.[@pone.0087191-Hilibrand2]         2002            131             59                 53                    58                 66M/65F            30M/29F            57m              73m                             Autograft                                          Autograft
  Jeffrey et al.[@pone.0087191-Wang2]                2001            32              20            51.5(17--80)            27M/25F           3.6 years (2-7Y)      Allograft        Allograft                                                                          
  Emery et al.[@pone.0087191-Emery1]                 1998            45              55             58(27--88)             69M/38F              \>2 years          Autograft        Autograft                                                                          
  Swank et al.[@pone.0087191-Swank1]                 1997            38              26             51(30--78)             37M/27F             39m(12--81m)        Allograft        Allograft                                                                          
  Yonenobu et al.[@pone.0087191-Yonenobu1]           1985            50              21              51.4±8.6              52.8±8.5               46M/4F            20M/1F        54m(14--157m)     30m(12--88m)                        Autograft                                          Autograft

2.5 Statistical analysis {#s2e}
------------------------

All statistical tests were performed using the Review Manager software (RevMan Version 5.1; The Cochrane Collaboration, Copenhagen, Denmark). Assessment for statistical heterogeneity was done using the Chi-squared and I-squared tests [@pone.0087191-Higgins1]. Values of I^2^ greater than 50% were considered to indicate substantial heterogeneity. A probability of *p*\<0.05 was considered to be statistically significant. The results were expressed in terms of mean difference (MD) and 95% CI for continuous outcomes and in terms of odds ratio (OR) and 95% confidence interval (95% CI) for dichotomous outcomes. A random effects model was used for heterogeneous data; otherwise, a fixed effect model was used. Collected data were checked and entered into the computer by the two reviewers (Han and Liu).

Results {#s3}
=======

3.1 Search results {#s3a}
------------------

Initial electronic database searches yielded 2157 relevant titles. Of these, 2075 were excluded after review of the abstract and title for being unrelated to the topic at hand, not human studies, not comparative studies, or for being case reports or review articles. A further 63 studies were subsequently excluded due to failure to meet the inclusion criteria after review of the full text. One article were excluded due to insufficient follow-up [@pone.0087191-Burkhardt1]. An additional two studies were excluded due to other interventions [@pone.0087191-Hilibrand1], [@pone.0087191-Lee1]. Two articles identified were written by the same author [@pone.0087191-Liu1], [@pone.0087191-Liu2], and we selected the one most recently published [@pone.0087191-Liu2]. As a result, fifteen studies fulfilled the eligibility criteria [@pone.0087191-Oh1], [@pone.0087191-Liu2]--[@pone.0087191-Yonenobu1]. Study inclusion is detailed in [*Fig 1*](#pone-0087191-g001){ref-type="fig"}. A meta-analysis was conducted using these fifteen studies.

![Flow diagram detailing study inclusion.](pone.0087191.g001){#pone-0087191-g001}

3.2 Demographic characteristics and quality assessment {#s3b}
------------------------------------------------------

The demographic characteristics of the included studies are presented in [*Tables 1*](#pone-0087191-t001){ref-type="table"} *--* [*3*](#pone-0087191-t002){ref-type="table"}. The 15 studies included a total of 1372 patients: 734 who underwent ACDF and 638 who underwent ACCF with various grafts, including autografts, allografts, and cage and/or plate systems. All participants in the fifteen studies had undergone follow-up for at least 2 years. No randomized controlled trials were identified; all fifteen studies included were retrospective studies. The quality of each study was assessed using the Newcastle Ottawa Quality Assessment Scale (NOQAS). This scale for non-randomized case controlled studies and cohort studies was used to allocate a maximum of nine points for the quality of selection, comparability, exposure, and outcomes for study participants. Of the studies, six scored 8 points and nine scored 7 points. Hence, the studies were of a relatively high quality ([*Table 4*](#pone-0087191-t003){ref-type="table"}).

10.1371/journal.pone.0087191.t002

###### Details and heterogeneity of clinical outcome measurement of the included studies.

![](pone.0087191.t002){#pone-0087191-t002-2}

  Study                                              Hospital Stay   Operation Time   Blood Loss   JOA   VAS   NDI   Odom Criteria   Fusion Rate   Cobb angles of C2--C7   Segmental angle   Complications
  ------------------------------------------------- --------------- ---------------- ------------ ----- ----- ----- --------------- ------------- ----------------------- ----------------- ---------------
  **Li et al.** [@pone.0087191-Li1]                       NA               NA             NA       YES   NA    NA         NA             YES                YES                  NA               NA
  **Liu et al.** [@pone.0087191-Liu2]                     NA              YES            YES       YES   NA    YES        YES            YES                YES                  YES              YES
  **Kyung et al.** [@pone.0087191-Song1]                  YES             YES            YES       YES   YES   NA         NA             YES                YES                  NA               YES
  **Lin et al.** [@pone.0087191-Lin1]                     NA              YES            YES       YES   NA    YES        YES            YES                NA                   YES              YES
  **Guo et ai.** [@pone.0087191-Guo1]                     NA              YES            YES       YES   NA    NA         NA             YES                YES                  YES              YES
  **Park et al.** [@pone.0087191-Park1]                   NA               NA             NA       NA    NA    NA         NA             NA                 YES                  NA               NA
  **Oh et al.** [@pone.0087191-Oh1]                       YES             YES            YES       YES   YES   NA         NA             YES                YES                  NA               NA
  **Uribe et al.** [@pone.0087191-Uribe1]                 NA              YES            YES       NA    NA    NA         YES            YES                NA                   NA               YES
  **Hwang et al.** [@pone.0087191-Hwang1]                 YES              NA             NA       YES   YES   NA         NA             YES                YES                  NA               YES
  **Nirala et al.** [@pone.0087191-Nirala1]               NA               NA             NA       NA    NA    NA         YES            YES                NA                   NA               YES
  **Hilibrand et al.** [@pone.0087191-Hilibrand2]         NA               NA             NA       NA    NA    NA         YES            YES                NA                   NA               US
  **Jeffrey et al.** [@pone.0087191-Wang2]                NA               NA             NA       NA    NA    NA         YES            YES                NA                   NA               US
  **Emery et al.** [@pone.0087191-Emery1]                 NA               NA             NA       NA    NA    NA         NA             YES                NA                   NA               US
  **Swank et al.** [@pone.0087191-Swank1]                 NA               NA             NA       NA    NA    NA         YES            NA                 NA                   NA               US
  **Yonenobu et al.** [@pone.0087191-Yonenobu1]           NA               NA             NA       NA    NA    NA         NA             NA                 NA                   NA               YES
  **Number of patients involved**                         133             446            446       517   133   228        805           1140                432                  295              749

10.1371/journal.pone.0087191.t003

###### Details of complications of the included studies.

![](pone.0087191.t003){#pone-0087191-t003-3}

  Study                                            Dysphagia   Hoarseness   C5 palsy   Infection   Cerebral fluid leakage   Donor site pain   Epidural hematoma   Graft related   Hardware related
  ----------------------------------------------- ----------- ------------ ---------- ----------- ------------------------ ----------------- ------------------- --------------- ------------------
  **Liu et al.** [@pone.0087191-Liu2]                 YES         YES         YES         YES               YES                   NA                 YES               YES              YES
  **Kyung et al.** [@pone.0087191-Song1]              YES         YES          NA         NA                YES                   YES                NA                YES              YES
  **Lin et al.** [@pone.0087191-Lin1]                 YES         YES         YES         NA                YES                   NA                 YES               YES               NA
  **Guo et ai.** [@pone.0087191-Guo1]                 NA           NA          NA         NA                YES                   NA                 YES               NA               YES
  **Uribe et al.** [@pone.0087191-Uribe1]             NA           NA          NA         NA                 NA                   NA                 NA                YES               NA
  **Hwang et al.** [@pone.0087191-Hwang1]             YES         YES          NA         NA                 NA                   YES                NA                NA                NA
  **Nirala et al.** [@pone.0087191-Nirala1]           YES         YES          NA         YES                NA                   YES                NA                YES               NA
  **Yonenobu et al.** [@pone.0087191-Yonenobu1]       NA           NA          NA         YES                NA                   NA                 YES               YES               NA
  **Number of patients involved**                     531         531         228         380               335                   303                366               620              215

10.1371/journal.pone.0087191.t004

###### Quality assessment according to the Newcastle--Ottawa scale of the included studies.

![](pone.0087191.t004){#pone-0087191-t004-4}

  Study                                          Selection   Comparability   Exposure   Total score
  --------------------------------------------- ----------- --------------- ---------- -------------
  Li et al. [@pone.0087191-Li1]                      3             2            3            8
  Liu et al. [@pone.0087191-Liu2]                    3             2            3            8
  Kyung et al. [@pone.0087191-Song1]                 3             2            3            8
  Lin et al. [@pone.0087191-Lin1]                    3             2            3            8
  Guo et ai.[@pone.0087191-Guo1]                     3             2            3            8
  Park et al. [@pone.0087191-Park1]                  2             2            3            7
  Oh et al. [@pone.0087191-Oh1]                      2             2            3            7
  Uribe et al. [@pone.0087191-Uribe1]                2             2            3            7
  Hwang et al. [@pone.0087191-Hwang1]                3             2            3            8
  Nirala et al. [@pone.0087191-Nirala1]              2             2            3            7
  Hilibrand et al. [@pone.0087191-Hilibrand2]        2             2            3            7
  Jeffrey et al. [@pone.0087191-Wang2]               2             2            3            7
  Emery et al. [@pone.0087191-Emery1]                2             2            3            7
  Swank et al. [@pone.0087191-Swank1]                2             2            3            7
  Yonenobu et al. [@pone.0087191-Yonenobu1]          2             2            3            7

3.3 Clinical outcome analysis {#s3c}
-----------------------------

### 3.3.1 Hospital stay, blood loss and operation time {#s3c1}

Three studies were selected for the meta-analysis for hospital stay [@pone.0087191-Oh1], [@pone.0087191-Song1], [@pone.0087191-Uribe1]. A total of 133 patients from 3 studies (66 patients for ACDF and 67 patients for ACCF) were included in this comparison. The available data demonstrated low heterogeneity (I^2^ = 27%). The hospital stay in the ACDF group was superior to the ACCF group (MD = −5.60, 95% CI = −7.09 to −4.11; *p*\<0.00001; [*Fig 2*](#pone-0087191-g002){ref-type="fig"}). Six studies reported intraoperative blood loss and operation time; a total of 446 patients from 6 studies (250 patients for ACDF and 196 patients for ACCF) were included. Blood loss was significantly higher in the ACCF group compared with ACDF (MD = −151.35, 95% CI = −253.22 to −49.48; *p* = 0.004; [*Fig 3*](#pone-0087191-g003){ref-type="fig"}). There was no significant difference in operation time between the two treatment groups (MD = −9.34, 95% CI = −42.99 to 24.31; *p* = 0.59; [*Fig 4*](#pone-0087191-g004){ref-type="fig"}). There was significant heterogeneity in blood loss and operation time between the studies (heterogeneity: I^2^ = 98%), which can not be explained by our predefined subgroup analysis. Therefore, the quality of evidence for this outcome is low.

![The forest plot for hospital stay between ACDF group and ACCF group, CI  =  confidence interval, df  =  degrees of freedom, IV  =  independent variable,SD  =  standard deviation.](pone.0087191.g002){#pone-0087191-g002}

![The forest plot for blood loss between ACDF group and ACCF group, CI  =  confidence interval, df  =  degrees of freedom, IV  =  independent variable, SD  =  standard deviation.](pone.0087191.g003){#pone-0087191-g003}

![The forest plot for operation time between ACDF group and ACCF group, CI  =  confidence interval, df  =  degrees of freedom, IV  =  independent variable,SD  =  standard deviation.](pone.0087191.g004){#pone-0087191-g004}

### 3.3.2 JOA, VAS, NDI and Odom criteria {#s3c2}

The clinical outcome for 571 patients from seven studies was assessed using the JOA score (282 in the ACDF group and 235 in the ACCF group). There was no significant difference in the final follow-up JOA score between the two groups (MD = 0.24, 95% CI = −0.10 to 0.57; *p* = 0.16), with low heterogeneity (I^2^ = 7%; [*Fig 5*](#pone-0087191-g005){ref-type="fig"}). Three studies included reports of neck pain in the VAS scores (66 in the ACDF group and 67 in the ACCF group). There was no difference in neck VAS score between ACDF and ACCF (MD = −0.06, 95% CI = −0.81to 0.70; *p* = 0.88) with no heterogeneity (I^2^ = 0%; [*Fig 6*](#pone-0087191-g006){ref-type="fig"}). Two studies reported a final follow-up NDI score; there was no significant difference between the two treatment groups (MD = −1.37, 95% CI = −3.17 to 0.43; *p* = 0.14; [*Fig 7*](#pone-0087191-g007){ref-type="fig"}). Seven trials reported the Odom criteria (428 in the ACDF group and 377 in the ACCF group). The patients with excellent or good clinical outcomes were similar in the two groups (OR = 0.88, 95% CI = 0.60 to 1.30; *p* = 0.53) and the available data demonstrated low heterogeneity (I^2^ = 5%; [*Fig 8*](#pone-0087191-g008){ref-type="fig"}).

![The forest plot for JOA score between ACDF group and ACCF group, CI  =  confidence interval, df  =  degrees of freedom, IV  =  independent variable, SD  =  standard deviation, JOA =  the Japanese Orthopedic Association scores.](pone.0087191.g005){#pone-0087191-g005}

![The forest plot for VAS score between ACDF group and ACCF group, CI  =  confidence interval, df  =  degrees of freedom, IV  =  independent variable,SD  =  standard deviation, VAS =  visual analogue score of neck.](pone.0087191.g006){#pone-0087191-g006}

![The forest plot for NDI score between ACDF group and ACCF group, CI  =  confidence interval, df  =  degrees of freedom, IV  =  independent variable,SD  =  standard deviation, NDI =  neck disability index.](pone.0087191.g007){#pone-0087191-g007}

![The forest plot for Odom\'s criteria between ACDF group and ACCF group,CI = confidence interval, df = degrees of freedom,MH = Mantel-Haenszel statistical method, SD  =  standard deviation.](pone.0087191.g008){#pone-0087191-g008}

### 3.3.3 Radiographic assessment (fusion rate, Cobb angle of C2--C7, and segmental angle) {#s3c3}

Twelve studies used radiographs to assess the consolidation of the fusion (n = 1140 patients, 601 in the ACDF group and 539 in the ACCF group). The incidence of fusion was not different between the two groups (OR = 1.17, 95% CI = 0.34 to 4.11; *p* = 0.80), with moderate heterogeneity (I^2^ = 72%; [*Fig 9*](#pone-0087191-g009){ref-type="fig"}). Six trials reported the Cobb angle of C2--C7 (243 in the ACDF group and 189 in the ACCF group) and three trials reported the segmental angle (169 in the ACDF group and 126 in the ACCF group). Statistical analysis showed significant differences between the ACDF and ACCF groups for changes of the angle of C2--C7 (MD = 3.70, 95% CI = 0.96 to 6.45; *p* = 0.008; I^2^ = 69%; [*Fig 10*](#pone-0087191-g010){ref-type="fig"}) and the segmental angle (MD = 3.38, 95% CI = 2.54 to 4.22; *p*\<0.00001; I^2^ = 6%; [*Fig 11*](#pone-0087191-g011){ref-type="fig"}).

![The forest plot for fusion rate between ACDF group and ACCF group,CI = confidence interval, df = degrees of freedom,MH = Mantel-Haenszel statistical method, SD  =  standard deviation.](pone.0087191.g009){#pone-0087191-g009}

![The forest plot for cobb angles of C2--C7 score between ACDF group and ACCF group, CI  =  confidence interval, df  =  degrees of freedom, IV  =  independent variable,SD  =  standard deviation.](pone.0087191.g010){#pone-0087191-g010}

![The forest plot for cobb angles of segmental between ACDF group and ACCF group, CI  =  confidence interval, df  =  degrees of freedom, IV  =  independent variable,SD  =  standard deviation.](pone.0087191.g011){#pone-0087191-g011}

### 3.3.4 Complications {#s3c4}

Eight studies reported complications (n = 749 patients, 382 in the ACDF group and 367 in the ACCF group), however, the records of post-operative complications were variable. Some studies described all complications, whereas some provided only the major complications. The incidence of complications was significantly higher in the ACCF group than in the ACDF group (OR = 0.50, 95% CI = 0.35 to 0.73; *p* = 0.0003), with no heterogeneity (I^2^ = 0%; [*Fig 12*](#pone-0087191-g012){ref-type="fig"}). There was a significant difference in graft-related complications, however, there were no differences in dysphagia, hoarseness, C5 palsy, infection, cerebral fluid leakage, donor site pain, epidural hematoma, or hardware-related complications ([*Fig 13*](#pone-0087191-g013){ref-type="fig"}).

![The forest plot for totally complications between ACDF group and ACCF group,CI = confidence interval, df = degrees of freedom,MH = Mantel-Haenszel statistical method, SD  =  standard deviation.](pone.0087191.g012){#pone-0087191-g012}

![The forest plot for the subgroups of complication between ACDF group and ACCF group,CI = confidence interval, df = degrees of freedom,MH = Mantel-Haenszel statistical method, SD  =  standard deviation.](pone.0087191.g013){#pone-0087191-g013}

Discussion {#s4}
==========

Although the surgical treatment for cervical spondylotic myelopathy (CSM) has a history going back sixty years, the selection of surgical procedures remains controversial and challenging. The common surgical procedures used include the anterior, posterior, and combined anteroposterior approaches. Anterior approaches to the cervical spine are recognized as a reliable and effective method to treat CSM and they have been widely accepted as an appropriate operative procedure. Anterior decompression and fusion can remove the compressive pathology and reconstruct the alignment of the cervical spine, yielding good clinical results. The type of decompression and reconstruction technique are the two important decisions to be made. Anterior decompression and fusion include cervical discectomy with fusion (ACDF) and anterior cervical corpectomy with fusion (ACCF) [@pone.0087191-Grob1]--[@pone.0087191-Ba1], however, the ideal anterior decompression method is controversial.

Although some relevant studies comparing the ACDF and ACCF have been reported, the evidence regarding whether ACDF is superior to ACCF remains insufficient, owing to ambiguous results. We therefore conducted a meta-analysis to determine whether ACDF is associated with better clinical outcomes compared with ACCF. In this meta-analysis, we used strict eligibility criteria. Although no RCT studies were included in our study, all selected studies were of high quality according to the Newcastle Ottawa Quality Assessment Scale (NOQAS) and the baseline variables were similar. Thus, we considered the included reports suitable for meta-analysis. Clinical outcomes (hospital stay, JOA, VAS, NDI score and Odom criteria), surgical outcomes (operation time, blood loss, and perioperative complications), and radiographic outcomes (rate of fusion, Cobb angle of C2--C7, and segmental angle) were assessed in the meta-analysis.

There was a significant difference in hospital stay between ACDF and ACCF. A shorter hospital stay makes ACDF a better proposition than ACCF. In the meta-analysis of JOA, VAS and NDI, scores were similar in the two groups. However, both groups demonstrated a significant post-operative increase in JOA scores and decrease in VAS scores, an increase that was maintained at the final follow-up. There was also no difference in Odom criteria between the two groups. These findings indicate that both groups achieved adequate decompression of the spinal cord and nerve roots that were compressed by herniated discs or osteophytes, and that these patients benefited from reconstruction of the spinal column.

In the meta-analysis, operation time and blood loss were selected to evaluate surgical trauma. Both the overall and subgroup analyses revealed that although blood loss was significantly higher in the ACCF group than in the ACDF group, the operation time was similar in the two groups. This indicates that, in the treatment of CSM, the surgical trauma associated with ACCF is higher than with ACDF. We selected the total complications for meta-analysis to evaluate complication-related outcomes, and found a higher incidence of complications with ACCF than with ACDF (OR = 0.50, 95% CI = 0.35 to 0.73, *p* = 0.0003). Subgroup analysis observed apart from graft related complications is significantly higher in the ACCF group (*p* = 0.005), while other subgroups, namely dysphagia, hoarseness, C5 palsy, infection, cerebral fluid leakage, donor site pain, epidural hematoma and hardware-related complications, were similar between the two groups. There was no heterogeneity between the two groups for total complications for all subgroups (I^2^ = 0). Considering the most significantly different complications were graft-related, this seemed to be due to technical reasons. Some authors consider that ACDF offers more fixation points to hold the construct rigidly in place, but ACCF provide only two points of fixation. The lack of fixation points may therefore be the reason for the higher graft-related complication rates in the ACCF group [@pone.0087191-Vaccaro1], [@pone.0087191-Sasso1]. There were similar rates of dysphagia and hoarseness between the two groups in this meta-analysis; and they are the most common sequelae. Some studies have reported that post-operative dysphagia occurs in 2--48% of patients [@pone.0087191-Clements1] and post-operative hoarseness occurs in 3--11% of patients [@pone.0087191-Apfelbaum1], [@pone.0087191-Heeneman1], but these symptoms are frequently transient. The etiology of dysphagia may be multifactorial, including hematoma formation and prolonged retraction and denervation of the upper esophagus by injury to the pharyngeal plexus [@pone.0087191-Welsh1]. The etiology of post-operative hoarseness has been postulated to be related to direct injury to the recurrent or superior laryngeal nerves.

Regarding the fusion rate, in the current meta-analysis, patients who underwent ACDF were not significantly different from those who underwent ACCF (*p* = 0.63). However, some studies have reported that ACDF has a high rate of non-union, because they consider that ACCF can not only easily resolve retro-vertebral compressive pathology but also reduce the graft-host interface [@pone.0087191-Song1], [@pone.0087191-Guo1], [@pone.0087191-Nirala1], [@pone.0087191-Hilibrand2]. However, meta-analysis is a statistical analysis of data collected from several different studies on the same problem, pooling outcomes in order to arrive at a more unbiased and scientific conclusion [@pone.0087191-Dickman1], [@pone.0087191-Haher1], so we regard the fusion rate to be similar between the two groups. In this meta-analysis, both the ACDF and ACCF groups had significantly increased lordosis of C2--C7 and fusion segments, but the increase was greater in the ACDF group than in those with ACCF. Some studies have reported that ACDF can provide multiple points of distraction and fixation in addition to the graft and interbody space shaping, and can also restore alignment by pulling the involved vertebral bodies toward the lordotic ventral plate. However, ACCF grafts may straighten the cervical spinal column between the remaining vertebral bodies [@pone.0087191-Lin1].

There are several limitations to this meta-analysis. Firstly, none of the studies included in the meta analysis were RCTs. Secondly, there was a variable length of follow-up between the studies and this is particularly important for evaluating surgery results. Thirdly, clinical heterogeneity might be caused by the various indications for surgery and the surgical technologies used at the different treatment centers. Finally, these studies lack a gold standard outcome to evaluate the post-operative clinical effect.

Conclusion {#s4a}
----------

Based on a systematic review of the literature and meta-analysis of ACDF and ACCF for the treatment of CSM, the following conclusions may be drawn. The clinical outcomes of ACDF are superior to ACCF for hospital stay, blood loss, complications and increased cervical lordosis, but the outcomes of operation time, fusion rate, Odom criteria and JOA, VAS, and NDI scores are equivalent between the two groups. This meta-analysis highlights the surgical and outcome differences between ACDF and ACCF in the treatment of CSM. Due to the varying pathoanatomy of spinal cord compression leading to CSM, individualized treatment decisions should be based upon the location of the compressive pathology. If significant retrovertebral compression on the spinal cord is present then ACCF is the preferred treatment. In the absence of significant retrovertebral disease, ACDF is the preferred treatment. However future studies with high methodological quality and long-term follow-up periods are needed for updated meta-analyses, in order to better evaluate the two procedures for CSM treatment.
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